Ayurcann Holdings Corp. (CSE: AYUR) (the “ Company ” or “ Ayurcann ”), a Canadian extraction company specializing in the processing of cannabis and hemp to produce oils and various derivative products, is pleased to announce that it has entered into a joint venture agreement to manufacture proprietary products with Bazelet Nehushtan Ltd. and/or Bazelet Development and Technologies Ltd. (“ Bazelet ”), a licensed medical cannabis processor based in Israel. Bazelet, one of the largest medical cannabis companies in Israel, has launched multiple lines of terpene-enriched cannabis oils, each one of which being specifically designed for one of various indications, symptoms and personal needs. The Company’s terpene-enriched products are optimized for woman health, for elderly population needs, for specific types of pains (muscle, joint, neuropathic), and for improved night sleep, et cetera. Bazelet has developed proprietary IP for form...
Hide player controls
Hide resume playing